Biological E to invest Rs 1,800 crore for expansion

The vaccine manufacturer Biological E on revealed plans for growth that will cost over Rs 1,800 crore and create jobs for more than 2500 employees across its three plants in Genome Valley.

A press statement from the state government states that the expansion is mainly intended to increase vaccine production along with generic injectables and R&D.

The declaration was made during a meeting between Biological E Mahima Datla, Managing Director, and IT and Industries Minister KT Rama Rao.

Rama Rao said, “I’m delighted to announce the expansion plans of Biological E in Genome Valley. Hyderabad is already known as the “vaccine Capital of the World” and this expansion further accelerates our strength to serve the world with live saving vaccines.”

 

Site Moved. Visit our New Website

We have moved this news site from this URL to https://www.newprojectstracker.com/capex-news .

Visit this site for regular updates

Buy Latest Research Reports

Related Posts